Pasithea Therapeutics Corp. – Transcripts

NASDAQ: KTTA
Share price (6/2/26): $0.65
Market cap (6/2/26): $21.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Transcripts

All mentions

CY 2026

Other Revised 02/27/26 Pasithea Therapeutics Corp. Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference, Feb-26-2026 04:00 PM 02/26/26

CY 2022

Other Revised 10/12/22 AlloMek Therapeutics LLC, Pasithea Therapeutics Corp. - M&A Call 10/12/22

Other Revised 06/22/22 Pasithea Therapeutics Corp., Alpha-5 Integrin, LLC - M&A Call 06/22/22